Revision Hip Replacement - Medical Devices Pipeline Assessment, 2020

Publication Month: Sep 2020 | No. of Pages: 31 Published By: GlobalData
Single User License: US $ 2500
Corporate User License: US $ 7500

Revision Hip Replacement - Medical Devices Pipeline Assessment, 2020

Summary

GlobalData's Medical Devices sector report, "Revision Hip Replacement- Medical Devices Pipeline Assessment, 2020 " provides comprehensive information about the Revision Hip Replacement pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Revision Hip Replacement is the replacement of the failed Primary Hip implants with a new implant.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Revision Hip Replacement under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Revision Hip Replacement devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Revision Hip Replacement devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Revision Hip Replacement Overview
3 Products under Development
3.1 Revision Hip Replacement - Pipeline Products by Stage of Development
3.2 Revision Hip Replacement - Pipeline Products by Territory
3.3 Revision Hip Replacement - Pipeline Products by Regulatory Path
3.4 Revision Hip Replacement - Pipeline Products by Estimated Approval Date
4 Revision Hip Replacement - Pipeline Products under Development by Companies
4.1 Revision Hip Replacement Companies - Pipeline Products by Stage of Development
4.2 Revision Hip Replacement - Pipeline Products by Stage of Development
5 Revision Hip Replacement Companies and Product Overview
5.1 Corin Group Ltd Company Overview
5.1.1 Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.2 Exactech Inc Company Overview
5.2.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 JRI Orthopaedics Ltd Company Overview
5.3.1 JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.4 Limacorporate SpA Company Overview
5.4.1 Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview
5.5 Pro-Dex Inc Company Overview
5.5.1 Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Revision Hip Replacement- Recent Developments
6.1 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
6.2 May 28, 2020: Conformis announces settlement of patent dispute
6.3 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
6.4 Jan 08, 2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer
6.5 Jan 06, 2020: Exactech announces leadership transition
6.6 Nov 05, 2019: Zimmer Biomet announces third quarter 2019 financial results
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

Tables and Figures

List of Tables
Table 1: Revision Hip Replacement - Pipeline Products by Stage of Development
Table 2: Revision Hip Replacement - Pipeline Products by Territory
Table 3: Revision Hip Replacement - Pipeline Products by Regulatory Path
Table 4: Revision Hip Replacement - Pipeline Products by Estimated Approval Date
Table 5: Revision Hip Replacement Companies - Pipeline Products by Stage of Development
Table 6: Revision Hip Replacement - Pipeline Products by Stage of Development
Table 7: Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Trinity Plus - Product Status
Table 9: Trinity Plus - Product Description
Table 10: Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: Alteon Revision Modular System - Product Status
Table 12: Alteon Revision Modular System - Product Description
Table 13: Hip Revision System - Product Status
Table 14: Hip Revision System - Product Description
Table 15: JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Amace Acetabular Revision System - Product Status
Table 17: Amace Acetabular Revision System - Product Description
Table 18: Furlong H-A.C. Revision Hip Stem - Product Status
Table 19: Furlong H-A.C. Revision Hip Stem - Product Description
Table 20: Furlong Securus Femoral Revision System - Product Status
Table 21: Furlong Securus Femoral Revision System - Product Description
Table 22: MRP-Titan - Product Status
Table 23: MRP-Titan - Product Description
Table 24: MRS Comfort Revision Cup - Product Status
Table 25: MRS Comfort Revision Cup - Product Description
Table 26: Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 27: DELTA-Revision TT - Product Status
Table 28: DELTA-Revision TT - Product Description
Table 29: Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Acetabular Cup Revision Tool - Product Status
Table 31: Acetabular Cup Revision Tool - Product Description
Table 32: Glossary

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets